DREDGECAP
NYSE·Surgical & Medical Instruments & Apparatus
INFU

InfuSystem Holdings, Inc

InfuSystem Holdings, Inc (ticker: INFU) is an NYSE-listed surgical & medical instruments & apparatus company. DredgeCap's structured extraction of INFU's SEC filings surfaces 5 active risk signals, including 4 late-filing signals, and 1 auditor-change signal. INFU reported $33.68M in revenue and $1.02M for the period ending 2026-03-31, with operating cash flow of $970K. Cash and equivalents stood at $2.11M (up 39.8% year-over-year). Total assets of $98.66M exceed total liabilities of $39.91M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

Is INFU diluting shareholders? — Data Unavailable

InfuSystem Holdings, Inc's dilution status could not be determined from the SEC filings currently cached. We need at least one annual filing (10-K, 20-F, 40-F) with parseable share-count cover-page text to compute a trend.

Growth Rate
Unavailable
Current Shares
Not parseable
ATM Facility
Not detected
Convertible Notes
Not detected
Reverse Split
Not detected

What Dilution Means for INFU Shareholders

Dilution refers to the reduction in existing shareholders' percentage ownership when a company issues new shares. Companies dilute for multiple legitimate reasons — funding growth, acquiring other companies, compensating employees with equity, or converting debt to equity. Whether dilution is good or bad depends on what the new capital is being used for and whether per-share value grows faster than the share count.

The dilution mechanism shareholders should monitor most closely is the presence of an ATM (at-the-market) equity facility. ATMs give the company standing authority to issue new shares into the open market at any time, often without separate shareholder notice. They create continuous-issuance overhang — even days when no new shares are sold, the facility itself weighs on the stock as supply might appear at any moment. InfuSystem Holdings, Inc's most recent annual filing does not mention an ATM facility — though that status can change with each new financing round.

Convertible notes are a separate forward-dilution mechanism: each note converts into shares at a defined price (or formula) at maturity, automatically expanding share count. The presence of large convertible-note balances on the balance sheet — even before conversion — is a material signal that future dilution is contractually scheduled. No convertible notes are mentioned in InfuSystem Holdings, Inc's most recent annual filing.

For broader context on INFU's risk profile, see the INFU Overview page. For audit-opinion status, see the Going Concern page.

Related on INFU

Auditor & opinion →
Who signs off on share-issuance disclosures.
Going-concern history →
Auditor + management language across filings.
Compare dilution across companies →
Ranked share-count growth across DredgeCap coverage.
Disclosure: Share counts are extracted from the cover page of INFU's cached SEC annual filings. Classification reflects share-count growth rate, presence of an ATM facility, and convertible-note disclosures at the time of the most recent annual filing. Status can change with new financing rounds. This page is not legal or investment advice.